Arcturus Therapeutics Holdings, Inc. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA.
Company profile
Website
CEO
Joseph E. Payne
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
711036989
Latest filings (excl ownership)
15-12B
Securities registration termination
1 Feb 13
POSASR
Automatic shelf registration (post-effective amendment)
30 Jan 13
S-3DPOS
Registration of securities, dividend or interest reinvestment plans, immediately effective (post-effective amendment)
30 Jan 13
25-NSE
Exchange delisting
22 Jan 13
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
22 Jan 13
8-K
Submission of Matters to a Vote of Security Holders
22 Jan 13
8-K
American Realty Capital Trust Stockholders Approve Merger with Realty Income
16 Jan 13
8-K
American Realty Capital Trust Announces 2012 Dividend Tax Status
16 Jan 13
8-K
American Realty Capital Trust Reminds Stockholders to Vote “For” the Realty Income Merger
14 Jan 13
DEFA14A
Additional proxy soliciting materials
14 Jan 13
Institutional ownership, Q1 2021
0.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 1 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 29.00 k |
Total shares | 1.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Sofos Investments | 1.00 | $29.00 k |